These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38877813)

  • 1. Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial.
    Rocca B; Tosetto A; Petrucci G; Rossi E; Betti S; Soldati D; Iurlo A; Cattaneo D; Bucelli C; Dragani A; Di Ianni M; Ranalli P; Palandri F; Vianelli N; Beggiato E; Lanzarone G; Ruggeri M; Carli G; Elli EM; Renso R; Randi ML; Bertozzi I; Loscocco GG; Ricco A; Specchia G; Vannucchi AM; Rodeghiero F; De Stefano V; Patrono C;
    Am J Hematol; 2024 Aug; 99(8):1462-1474. PubMed ID: 38877813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B
    De Stefano V; Rocca B; Tosetto A; Soldati D; Petrucci G; Beggiato E; Bertozzi I; Betti S; Carli G; Carpenedo M; Cattaneo D; Cavalca V; Dragani A; Elli E; Finazzi G; Iurlo A; Lanzarone G; Lissandrini L; Palandri F; Paoli C; Rambaldi A; Ranalli P; Randi ML; Ricco A; Rossi E; Ruggeri M; Specchia G; Timillero A; Turnu L; Vianelli N; Vannucchi AM; Rodeghiero F; Patrono C
    Blood Cancer J; 2018 Jun; 8(6):49. PubMed ID: 29880847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia.
    Rocca B; Tosetto A; Betti S; Soldati D; Petrucci G; Rossi E; Timillero A; Cavalca V; Porro B; Iurlo A; Cattaneo D; Bucelli C; Dragani A; Di Ianni M; Ranalli P; Palandri F; Vianelli N; Beggiato E; Lanzarone G; Ruggeri M; Carli G; Elli EM; Carpenedo M; Randi ML; Bertozzi I; Paoli C; Specchia G; Ricco A; Vannucchi AM; Rodeghiero F; Patrono C; De Stefano V
    Blood; 2020 Jul; 136(2):171-182. PubMed ID: 32266380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once versus twice daily aspirin after coronary bypass surgery: a randomized trial.
    Paikin JS; Hirsh J; Ginsberg JS; Weitz JI; Chan NC; Whitlock RP; Pare G; Eikelboom JW
    J Thromb Haemost; 2017 May; 15(5):889-896. PubMed ID: 28267249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with Essential Thrombocythemia may be Poor Responders to Enteric-Coated Aspirin, but not to Plain Aspirin.
    Scavone M; Rizzo J; Femia EA; Podda GM; Bossi E; Caberlon S; Paroni R; Cattaneo M
    Thromb Haemost; 2020 Oct; 120(10):1442-1453. PubMed ID: 32717754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin in polycythemia vera and essential thrombocythemia: current facts and perspectives.
    Landolfi R; Patrono C
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():83-6. PubMed ID: 8951777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis.
    Larsen ML; Pedersen OH; Hvas AM; Niekerk PBVK; Bønløkke S; Kristensen SD; Grove EL
    Platelets; 2019; 30(3):322-328. PubMed ID: 29442537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.
    Bethel MA; Harrison P; Sourij H; Sun Y; Tucker L; Kennedy I; White S; Hill L; Oulhaj A; Coleman RL; Holman RR
    Diabet Med; 2016 Feb; 33(2):224-30. PubMed ID: 26043186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.
    Tosetto A; Rocca B; Petrucci G; Betti S; Soldati D; Rossi E; Timillero A; Cavalca V; Porro B; Iurlo A; Cattaneo D; Bucelli C; Dragani A; Di Ianni M; Ranalli P; Palandri F; Vianelli N; Beggiato E; Lanzarone G; Ruggeri M; Carli G; Elli EM; Priolo S; Randi ML; Bertozzi I; Loscocco GG; Ricco A; Specchia G; Vannucchi AM; Rodeghiero F; De Stefano V; Patrono C;
    Clin Pharmacol Ther; 2022 Apr; 111(4):939-949. PubMed ID: 34743317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once- versus Twice-Daily Aspirin in Patients at High Risk of Thrombotic Events: Systematic Review and Meta-Analysis.
    Mainoli B; Duarte GS; Costa J; Ferreira J; Caldeira D
    Am J Cardiovasc Drugs; 2021 Jan; 21(1):63-71. PubMed ID: 32394295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin in essential thrombocythemia: status quo and quo vadis.
    Griesshammer M; Bangerter M; van Vliet HH; Michiels JJ
    Semin Thromb Hemost; 1997; 23(4):371-7. PubMed ID: 9263354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
    Capodanno D; Patel A; Dharmashankar K; Ferreiro JL; Ueno M; Kodali M; Tomasello SD; Capranzano P; Seecheran N; Darlington A; Tello-Montoliu A; Desai B; Bass TA; Angiolillo DJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):180-7. PubMed ID: 21386092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target.
    Pascale S; Petrucci G; Dragani A; Habib A; Zaccardi F; Pagliaccia F; Pocaterra D; Ragazzoni E; Rolandi G; Rocca B; Patrono C
    Blood; 2012 Apr; 119(15):3595-603. PubMed ID: 22234683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin in essential thrombocythemia. For whom? What formulation? What regimen?
    Cattaneo M
    Haematologica; 2023 Jun; 108(6):1487-1499. PubMed ID: 36632735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet thromboxane inhibition by low-dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation.
    Petrucci G; Giaretta A; Ranalli P; Cavalca V; Dragani A; Porro B; Hatem D; Habib A; Tremoli E; Patrono C; Rocca B
    Clin Transl Sci; 2022 Dec; 15(12):2958-2970. PubMed ID: 36200184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis.
    Yang M; Ye Z; Mei L; Ullah I; Tan C; Wang G; Gu Q; Lu Y; Abdus S; Shi L; Gong X; Bai J; Eikelboom JW; Li C
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1815-1823. PubMed ID: 34331551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple daily doses of acetyl-salicylic acid (ASA) overcome reduced platelet response to once-daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial.
    Paikin JS; Hirsh J; Ginsberg JS; Weitz JI; Chan NC; Whitlock RP; Pare G; Johnston M; Eikelboom JW
    J Thromb Haemost; 2015 Mar; 13(3):448-56. PubMed ID: 25546465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation.
    Petrucci G; Zaccardi F; Giaretta A; Cavalca V; Capristo E; Cardillo C; Pitocco D; Porro B; Schinzari F; Toffolo G; Tremoli E; Rocca B
    J Thromb Haemost; 2019 Jun; 17(6):885-895. PubMed ID: 30933424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
    Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy.
    Dragani A; Pascale S; Recchiuti A; Mattoscio D; Lattanzio S; Petrucci G; Mucci L; Ferrante E; Habib A; Ranelletti FO; Ciabattoni G; Davì G; Patrono C; Rocca B
    Blood; 2010 Feb; 115(5):1054-61. PubMed ID: 19887674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.